The researchers found that, compared to the AGHE, the Mediterranean diet resulted in a significant decrease in waist ...

Eli Lilly plans to launch its experimental oral weight-loss drug orforglipron in India, a senior executive said on Thursday, ...

A new analysis found that semaglutide and tirzepatide offer great health benefits over a lifetime, but the immense scale of ...

Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar ...

The deal returns the drug-maker to the growing market for obesity drugs after scrapping an experimental weight-loss pill.

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat ...

A new era of weight-loss treatment could soon trade needles for pills. Drugmakers behind GLP-1 injections like Wegovy and ...

An experimental GLP-1 pill called orforglipron promoted substantial weight loss without the need for weekly injections, ...

If you’re considering using medication to reach a healthy body weight, your first question might be: Are weight loss drugs ...

New York City doctors reveals how weight-loss drugs reduce inflammatory cytokines by decreasing fat cells, potentially preventing cancer and autoimmune diseases.

Makers of GLP-1 drugs, including Novo Nordisk and Eli Lilly, are close to releasing pills taken daily to help shed pounds as ...

“Semaglutide hits one receptor. It was the first one that came out,” Dr. Howe said. “Tirzepatide hits two receptors, and studies show that with tirzepatide, you get about a 32% weight loss compared to ...